For Admin
A Leading Company in Nasal Drug Delivery
SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.
3D Nasal Cast Model
Oct 6, 2025
SNBL’s Subsidiary, SNLD, Announces Posters to be Presented at the Upcoming International Congress of Parkinson’s Disease and Movement Disorders®
May 1, 2025
Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
Mar 24, 2025
SNBL’s Subsidiary, SNLD, Announces its Abstract Accepted at the Upcoming 77th American Academy of Neurology (AAN) 2025 Annual Meeting
2025|2024|2023|2022|2021|2020〜